Clinical trial
A Prospective, Randomised, Controlled Crossover Study on the Effectiveness of Bifidobacterium Adolescentis PRL2019 in the Treatment of Juvenile Fibromyalgia
NCT07738926 is registered in ClinicalTrials.gov with Istituto Giannina Gaslini as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Randomised, Controlled Crossover Study on the Effectiveness of Bifidobacterium Adolescentis PRL2019 in the Treatment of Juvenile Fibromyalgia
- Lead sponsor
- Istituto Giannina Gaslini
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- August 1, 2026
- Completion date
- September 30, 2026
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
fibromyalgia, fibromyalgia syndrome